Manganese complexes and manganese-based metal-organic frameworks as contrast agents in MRI and chemotherapeutics agents: Applications and prospects

R Zheng, J Guo, X Cai, L Bin, C Lu, A Singh… - Colloids and Surfaces B …, 2022 - Elsevier
Abstract Manganese-based Metal-organic Frameworks (Mn-MOFs) represents a unique sub-
class of MOFs with low toxicity, oxidative ability, and biocompatibility, which plays vital role in …

Recent development of copper (II) complexes of polypyridyl ligands in chemotherapy and photodynamic therapy

J Rani J, S Roy - ChemMedChem, 2023 - Wiley Online Library
Cancer is a deadly disease associated with abnormal cell growth and invasion to various
parts of the body. Many drugs such as cisplatin and carboplatin have been used for the …

Transition metals, their organic complexes, and radionuclides promising for medical use

AP Orlov, TP Trofimova, MA Orlova - Russian Chemical Bulletin, 2022 - Springer
A comparative analysis of the pharmaceutical and radiopharmaceutical activity of zinc,
copper, bismuth, and ruthenium ions was carried out. The prospects for their multimodal use …

Antiproliferative evaluation and supramolecular association in Mn (II) and Zn (II) bipyridine complexes: Combined experimental and theoretical studies

MK Bhattacharyya, A Gogoi, S Chetry, D Dutta… - Journal of Inorganic …, 2019 - Elsevier
Two new coordination complexes viz.[Mn 2 (μ‑O, O′‑4‑Mebz) 2 (bpy) 2 (μ 2‑H 2 O)(4‑Mebz)
2](1) and [Zn (bpy)(pdc)(H 2 O)]· 3.5 H 2 O (2)(where bpy= 2, 2′‑bipyridine, 4‑Mebz= 4 …

Synthesis, crystal structure and biological evaluation of a new dasatinib copper (II) complex as telomerase inhibitor

QP Qin, T Meng, MX Tan, YC Liu, XJ Luo… - European Journal of …, 2018 - Elsevier
A new copper (II) complex of dasatinib (DAS) was synthesized and characterized via ESI-
MS, UV–Vis, IR, single-crystal X-ray diffraction analysis, 1 H and 13 C NMR spectroscopy …

Binucleating hydrazonic ligands and their μ-hydroxodicopper (II) complexes as promising structural motifs for enhanced antitumor activity

JP Rada, BSM Bastos, L Anselmino… - Inorganic …, 2019 - ACS Publications
Very few inorganic antineoplastic drugs have entered the clinic in the last decades, mainly
because of toxicity issues. Because copper is an essential trace element of ubiquitous …

Copper (II) complexes with mixed heterocycle ligands as promising antibacterial and antitumor species

AM Rostas, M Badea, LL Ruta, IC Farcasanu, C Maxim… - Molecules, 2020 - mdpi.com
Complexes with mixed ligands [Cu (NN) 2 (pmtp)](ClO4) 2 ((1) NN: 2, 2′-bipyridine;(2) L: 1,
10-phenanthroline and pmpt: 5-phenyl-7-methyl-1, 2, 4-triazolo [1, 5-a] pyrimidine) were …

Di and tetranuclear Cu (II) complexes with simple 2-aminoethylpyridine: Magnetic properties, phosphodiester hydrolysis, DNA binding/cleavage, cytotoxicity and …

P Sureshbabu, QM Junaid, C Upadhyay, W Victoria… - Polyhedron, 2019 - Elsevier
Di and tetranuclear Cu (II) complexes,[Cu 2 (2-AEP) 4 (µ-Cl)](ClO 4) 3 (1) and [Cu 4 (µ 3-OH)
2 (µ 2-OH) 2 (2-AEP) 4 (µ 2-ClO 4) 2](ClO 4) 2 (2), with the simple 2-aminoethylpyridine (2 …

Biological activity of triazolopyrimidine copper (II) complexes modulated by an auxiliary NN-chelating heterocycle ligands

LL Ruta, IC Farcasanu, M Bacalum, M Răileanu… - Molecules, 2021 - mdpi.com
Novel complexes of type [Cu (NN)(dmtp) 2 (OH2)](ClO4) 2· dmtp ((1) NN: 2, 2′-
bipyridine;(2) L: 1, 10-phenantroline and dmtp: 5, 7-dimethyl-1, 2, 4-triazolo [1, 5-a] …

Antiproliferative and antibacterial properties of biocompatible copper (II) complexes bearing chelating N, N-heterocycle ligands and potential mechanisms of action

R Olar, M Badea, M Bacalum, M Răileanu, LL Ruţă… - Biometals, 2021 - Springer
In an attempt to propose new applications for the biomedical field, complexes with mixed
ligands {[Cu (bpy) 2 (μ 2 OClO 3)] ClO 4} n (1) and [Cu (phen) 2 (OH 2)](ClO 4) 2 (2)(bpy: 2 …